Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Reza Skandari"'
Publikováno v:
MDM Policy & Practice, Vol 8 (2023)
Background. Older and sicker adults with type 2 diabetes (T2D) were underrepresented in randomized trials of glucagon-like peptide 1 receptor-agonist (GLP1RA) and sodium-glucose cotransporter 2 inhibitors (SGLT2I), and thus, health benefits are uncer
Externí odkaz:
https://doaj.org/article/df61b103e67549318bbe630321c3b60d
Publikováno v:
Journal of General Internal Medicine. 38:147-155
Many patients do not receive guideline-recommended preventive, chronic disease, and acute care. One potential explanation is insufficient time for primary care providers (PCPs) to provide care.To quantify the time needed to provide 2020 preventive ca
Publikováno v:
SSRN Electronic Journal.
Autor:
Jin G. Choi, Aaron N. Winn, M. Reza Skandari, Melissa I. Franco, Erin M. Staab, Jason Alexander, Wen Wan, Mengqi Zhu, Elbert S. Huang, Louis Philipson, Neda Laiteerapong
Publikováno v:
Ann Intern Med
BACKGROUND: Guidelines recommend sodium–glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP1) receptor agonists as second-line therapy for patients with type 2 diabetes. Expanding their use as first-line therapy has been pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6899da3548c96dd28274a18fbcbfb847
https://europepmc.org/articles/PMC10155215/
https://europepmc.org/articles/PMC10155215/
Autor:
Valerie G. Press, Aaron N. Winn, Nisa M. Maruthur, Neda Laiteerapong, Wen Wan, Alexandra C. Knitter, Jason T. Alexander, Elizabeth L. Tung, Brittany Bindon, Kathryn E. Gunter, Sanjay Jumani, Shari Bolen, M. Reza Skandari, Elbert S. Huang, Meltem Zeytinoglu, Erin M. Staab, Melissa Franco, Louis H. Philipson, Celeste C. Thomas
Publikováno v:
J Gen Intern Med
BACKGROUND: Sodium-glucose cotransporter-2 inhibitors (SGLT2Is) are a recent class of medication approved for the treatment of type 2 diabetes (T2D). Previous meta-analyses have quantified the benefits and harms of SGLT2Is; however, these analyses ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b786027bdbf70dd209eec84fcca82eb
https://europepmc.org/articles/PMC8811049/
https://europepmc.org/articles/PMC8811049/
Autor:
Louis H. Philipson, Elizabeth L. Tung, Sanjay Jumani, Elbert S. Huang, Celeste C. Thomas, Aaron N. Winn, Wen Wan, Nisa M. Maruthur, Valerie G. Press, Shari Bolen, Alexandra C. Knitter, Kathryn E. Gunter, Meltem Zeytinoglu, Erin M. Staab, M. Reza Skandari, Neda Laiteerapong, Brittany Bindon, Jason T. Alexander, Melissa Franco
Publikováno v:
J Gen Intern Med
BACKGROUND: Previous meta-analyses of the benefits and harms of glucagon-like peptide-1 receptor agonists (GLP1RAs) have been limited to specific outcomes and comparisons and often included short-term results. We aimed to estimate the longer-term eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6797c44cccab2ba44982f15260747b8a
http://hdl.handle.net/10044/1/91768
http://hdl.handle.net/10044/1/91768
Autor:
Vivek Nair, Samuel Auger, Sara Kochanny, Frederick M. Howard, Daniel Ginat, Olga Pasternak-Wise, Aditya Juloori, Matthew Koshy, Evgeny Izumchenko, Nishant Agrawal, Ari Rosenberg, Everett E. Vokes, M. Reza Skandari, Alexander T. Pearson
Publikováno v:
JAMA Network Open. 5:e227240
Importance Clinical practice regarding posttreatment radiologic surveillance for patients with oropharyngeal carcinoma (OPC) is neither adapted to individual patient risk nor fully evidence based. Objectives To construct a microsimulation model for p
Autor:
Sandra A. Ham, Wei Wei Lee, Neda Laiteerapong, Marie T. Brown, Valerie G. Press, Tyler J Miksanek, M. Reza Skandari
Publikováno v:
Annals of internal medicine. 174(1)
Background Economic analyses of medical scribes have been limited to individual, specialty-specific clinics. Objective To determine the number of additional patient visits various specialties would need to recover the costs of implementing scribes in
Autor:
Nisa M. Maruthur, Erin M. Staab, Neda Laiteerapong, Jason T. Alexander, Kathryn E. Gunter, Sanjay Jumani, Alexandra C. Knitter, Wen Wan, Celeste C. Thomas, Reza Skandari, Brittany Bindon, Shari Bolen, Louis H. Philipson, Melissa Franco, Valerie G. Press, Elbert S. Huang, Meltem Zeytinoglu
Publikováno v:
Diabetes. 69
Background: Several large randomized trials suggest GLP-1RAs may reduce mortality in addition to lowering A1c in patients with T2D. Treatment algorithms from the ADA/EASD now recommend a GLP-1RA be initiated in patients with T2D who either have or ar
Autor:
Celeste C. Thomas, Reza Skandari, Brittany Bindon, Melissa Franco, Elbert S. Huang, Wen Wan, Louis H. Philipson, Shari Bolen, Jason T. Alexander, Erin M. Staab, Nisa M. Maruthur, Valerie G. Press, Neda Laiteerapong, Meltem Zeytinoglu, Sanjay Jumani, Kathryn E. Gunter, Alexandra C. Knitter
Publikováno v:
Diabetes. 69
Background: Several large randomized trials suggest SGLT2Is may reduce mortality in addition to lowering A1c in patients with T2D. Treatment algorithms from the ADA and EASD now recommend a SGLT2I be initiated in patients with T2D who have chronic ki